Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06542627 | RECRUITING | PreDiabetes

Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes: A Prospective Community-based (Workplace) Cohort Study
Sponsor:

hospital's Book of hospital

Information provided by (Responsible Party):

Cheol-Young Park

Brief Summary:

This study aimed to evaluate the effectiveness of use of Continuous Glucose Monitoring (CGM), combined with personalized dietary education and use of smartphone applications in improving glucose control and weight management.

Condition or disease

PreDiabetes

Diabetes Mellitus, Type 2

Intervention/treatment

Freestyle Libre

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 420 participants
Masking : NONE
Primary Purpose : TREATMENT
Official Title : Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes
Actual Study Start Date : 2023-05-22
Estimated Primary Completion Date : 2025-12-31
Estimated Study Completion Date : 2025-12-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 19 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Subjects over the age of 19
  • * Patients with type 2 diabetes
  • * Fasting blood glucose ≥ 126 mg/dL or
  • * HbA1c ≥ 6.5% or
  • * Type 2 diabetes by clinical history and treated with antidiabetic medications or lifestyle Modifications
  • * Patients with prediabetes
  • * Fasting blood glucose 100-125 mg/dL
  • * HbA1c 5.7-6.4%
  • * Willing to participate in the study
Exclusion Criteria
  • * Subjects less than 19 years old
  • * Patients with type 1 diabetes
  • * Pregnant at the time of screening or planning to become pregnant during the study
  • * Severe chronic diseases such as cancer, stroke, proliferative retinopathy, myocardial infarction, chronic renal disease, or amputation of a diabetic foot
  • * Diagnosed with or treated for myocardial infarction, stroke, end-stage renal disease, liver failure, or chronic lung disease within the past year
  • * Severe liver disease (e.g., cancer, liver cirrhosis, hepatitis B, hepatitis C)
  • * Diseases of the biliary tract, thyroid disorders, autoimmune disorders, or acute infections
  • * Planning to be admitted to a hospital within 2 months
  • * Unable to participate in the mobile intervention study as determined by the investigator
Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes: A Prospective Community-based (Workplace) Cohort Study

Location Details

NCT06542627

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

Korea, Republic of,

hospital's Book of hospital

Seoul, Korea, Republic of, 03181